| Summary | Date | Stock | Author | LTP | Target | Price at reco (Change since reco%) |
Upside(%) | Type | Report | Discuss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 27 May 2023 | Healthcare Global |
ICICI Securities Limited
|
550.30 | 330.00 | 293.75 (87.34%) | Target met |
Accumulate
|
Near-term prospects adequately priced in
ICICI Securities Limited
HealthCare Global Enterprises’ (HCG) Q4FY23 performance was in line with expectations. Traction was driven by mature centres though incremental revenue in new centres is not improving profitability in a meaningful way.
|
|||
| 27 May 2023 | Mahindra & Mahindra |
ICICI Securities Limited
|
2982.10 | 1478.00 | 1281.85 (132.64%) | Target met |
Buy
|
Gradual improvement in profitability continues
ICICI Securities Limited
Mahindra & Mahindra’s (M&M) Q4FY23 EBITDA margin at 12.4% (-60bps QoQ) was ~30bps lower than consensus as FES segment margin remained flat QoQ other than lower FES segment revenue mix QoQ. Automotive segment revenue increased 11% QoQ to Rs164bn, and FES revenue fell 11% QoQ to Rs55bn.
|
|||
| 27 May 2023 | ZF Commercial |
ICICI Securities Limited
|
12541.00 | 11433.00 | 10548.95 (18.88%) | Target met |
Buy
|
In-line result; growth momentum to remain intact
ICICI Securities Limited
ZF CV Control Systems India’s (ZFI) Q4FY23 EBITDA margin at 14.7% was up 104bps QoQ, and was purely driven by operating leverage as raw material prices did not benefit GM QoQ. Revenue increased 12% QoQ driven by CV OEM volume growth led by seasonality and pre-buying, other than expansion in after-market business.
|
|||
| 27 May 2023 | City Union Bank |
Edelweiss
|
177.65 | 175.00 | 139.40 (27.44%) |
Buy
|
|||||
| 27 May 2023 | Sun Pharmaceutical |
ICICI Direct
|
1744.80 | 1140.00 | 969.90 (79.89%) | Target met |
Buy
|
||||
| 27 May 2023 | Triveni Engineering |
ICICI Direct
|
407.05 | 370.00 | 274.30 (48.40%) | Target met |
Buy
|
||||
| 26 May 2023 | Wonderla Holidays |
SBI Securities
|
623.85 | 564.00 | 490.00 (27.32%) | Target met |
Buy
|
||||
| 26 May 2023 | Glenmark Pharma |
Geojit BNP Paribas
|
1398.20 | 638.00 | 591.40 (136.42%) | Target met |
Hold
|
||||
| 26 May 2023 | PVR INOX |
Geojit BNP Paribas
|
921.45 | 1700.00 | 1404.45 (-34.39%) | Target met |
Buy
|
||||
| 26 May 2023 | Tube Investments |
Geojit BNP Paribas
|
2860.30 | 2983.00 | 2781.60 (2.83%) | Target met |
Hold
|
||||
|
more
loading
|
|||||||||||
